Literature DB >> 33504930

Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population.

Juncheol Lee1, Bongyoung Kim2, Wonhee Kim3, Chiwon Ahn4, Hyun Young Choi3, Jae Guk Kim3, Jihoon Kim5, Hyungoo Shin6, Jun Goo Kang7,8, Shinje Moon9,10.   

Abstract

This study aimed to compare the accuracy of novel lipid indices, including the visceral adiposity index (VAI), lipid accumulation product (LAP), triglycerides and glucose (TyG) index, TyG-body mass index (TyG-BMI), and TyG-waist circumference (TyG-WC), in identifying insulin resistance and establish valid cutoff values. This cross-sectional study used the data of 11,378 adults, derived from the United States National Health and Nutrition Examination Survey (1999-2016). Insulin resistance was defined as a homeostasis model assessment-insulin resistance value above the 75th percentile for each sex and race/ethnicities. The area under the curves (AUCs) were as follows: VAI, 0.735; LAP, 0.796; TyG index, 0.723; TyG-BMI, 0.823, and; TyG-WC, 0.822. The AUCs for TyG-BMI and TyG-WC were significantly higher than those for VAI, LAP, and TyG index (vs. TyG-BMI, p < 0.001; vs. TyG-WC, p < 0.001). The cutoff values were as follows: VAI: men 1.65, women 1.65; LAP: men 42.5, women 42.5; TyG index: men 4.665, women 4.575; TyG-BMI: men 135.5, women 135.5; and TyG-WC: men 461.5, women 440.5. Given that lipid indices can be easily calculated with routine laboratory tests, these values may be useful markers for insulin resistance risk assessments in clinical settings.

Entities:  

Year:  2021        PMID: 33504930      PMCID: PMC7840900          DOI: 10.1038/s41598-021-82053-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  53 in total

Review 1.  Mechanisms for insulin resistance: common threads and missing links.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

2.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

3.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.

Authors:  R N Bergman; R Prager; A Volund; J M Olefsky
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.

Authors:  Juan F Ascaso; Susana Pardo; José T Real; Rosario I Lorente; Antonia Priego; Rafael Carmena
Journal:  Diabetes Care       Date:  2003-12       Impact factor: 19.112

5.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

6.  Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke.

Authors:  K Shinozaki; H Naritomi; T Shimizu; M Suzuki; M Ikebuchi; T Sawada; Y Harano
Journal:  Stroke       Date:  1996-01       Impact factor: 7.914

7.  Hyperinsulinemia as an independent risk factor for ischemic heart disease.

Authors:  J P Després; B Lamarche; P Mauriège; B Cantin; G R Dagenais; S Moorjani; P J Lupien
Journal:  N Engl J Med       Date:  1996-04-11       Impact factor: 91.245

8.  Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.

Authors:  J Kuusisto; L Mykkänen; K Pyörälä; M Laakso
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

9.  Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp.

Authors:  M S Greenfield; L Doberne; F Kraemer; T Tobey; G Reaven
Journal:  Diabetes       Date:  1981-05       Impact factor: 9.461

10.  Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome.

Authors:  Mark O Goodarzi; Stephen Erickson; Sidney C Port; Robert I Jennrich; Stanley G Korenman
Journal:  Metabolism       Date:  2003-06       Impact factor: 8.694

View more
  10 in total

1.  Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study.

Authors:  Nidhi H Patel; Michael T Osborne; Heather Teague; Philip Parel; Mariya Svirydava; Alexander V Sorokin; Meron Teklu; Grigory Manyak; Wunan Zhou; Carla Pantoja; Colin Scott; Martin P Playford; Promita Kapoor; Justin A Rodante; Andrew Keel; Marcus Chen; Ahmed Tawakol; Nehal N Mehta
Journal:  Atherosclerosis       Date:  2021-11-08       Impact factor: 5.162

2.  Association between visceral adiposity index and risk of prediabetes: A meta-analysis of observational studies.

Authors:  Dan Wang; Rui Fang; Haicheng Han; Jidong Zhang; Kaifei Chen; Xiaoqing Fu; Qinghu He; Yong Yang
Journal:  J Diabetes Investig       Date:  2021-10-21       Impact factor: 4.232

3.  Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients.

Authors:  Giulia di Girolamo; Irene Francesca Bracco; Alberto Portigliatti Pomeri; Soraya Puglisi; Francesco Oliva
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

4.  Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome.

Authors:  Markus Rohner; Robert Heiz; Simon Feldhaus; Stefan R Bornstein
Journal:  Horm Metab Res       Date:  2021-06-30       Impact factor: 2.936

5.  Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.

Authors:  Qi Zhao; Yu-Jing Cheng; Ying-Kai Xu; Zi-Wei Zhao; Chi Liu; Tie-Nan Sun; Yu-Jie Zhou
Journal:  Cardiovasc Diabetol       Date:  2021-09-18       Impact factor: 9.951

6.  Efficacy of Emilia coccinea aqueous extract on inhibition of α-amylase enzyme activity and insulin resistance in dexamethasone treated-rats.

Authors:  Sl Poualeu Kamani; J Kamgaing Waguia; D Miaffo; Ml Nchouwet; Cl Demeni Kadji; M T Wego Kamgaing; Rc Douho Djimeli; J Mzoyem Ngnitedem; A Kamanyi; Sl Wansi Ngnokam
Journal:  Metabol Open       Date:  2022-06-02

7.  Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population.

Authors:  Maritza Pérez-Mayorga; Jose P Lopez-Lopez; Maria A Chacon-Manosalva; Maria G Castillo; Johanna Otero; Daniel Martinez-Bello; Diego Gomez-Arbelaez; Daniel D Cohen; Patricio Lopez-Jaramillo
Journal:  Can J Gastroenterol Hepatol       Date:  2022-08-03

8.  Association Between Visceral Adiposity Index and Insulin Resistance: A Cross-Sectional Study Based on US Adults.

Authors:  Kai Jiang; Hong Luan; Xiaolu Pu; Mingxiang Wang; Jiahui Yin; Rongpeng Gong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

9.  Combined effect of pancreatic lipid content and gene variants (TCF7L2, WFS1 and 11BHSD1) on B-cell function in Middle Aged Women in a Post Hoc Analysis.

Authors:  Ákos Nádasdi; Viktor Gál; Tamás Masszi; Attila Patócs; Peter Igaz; Anikó Somogyi; Gábor Firneisz
Journal:  Diabetol Metab Syndr       Date:  2022-07-27       Impact factor: 5.395

10.  Triglyceride Glucose-Body Mass Index Is a Reliable Indicator of Bone Mineral Density and Risk of Osteoporotic Fracture in Middle-Aged and Elderly Nondiabetic Chinese Individuals.

Authors:  Zhangxin Wen; Yongfang Li; Lulu Xu; Chun Yue; Qinyi Wang; Rong Chen; Na Ding; Xiaoli Qu; Yangna Ou; Yanyi Yang; Zhifeng Sheng; Hong Liu
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.